<?xml version="1.0" encoding="UTF-8"?>
<p id="Par9">Many studies have been published on inter-individual pharmacokinetic variability of cyclosporine and Bayesian methods used to optimize dosing regimens. In all cases, population pharmacokinetic models were built, not individual predictive models [
 <xref ref-type="bibr" rid="CR5">5</xref>, 
 <xref ref-type="bibr" rid="CR6">6</xref>, 
 <xref ref-type="bibr" rid="CR8">8</xref>]. To date, no studies have been conducted to predict the achievement of the therapeutic target of the initial cyclosporine blood concentration after HSCT.
</p>
